Paul Haluska, M.D., Ph.D.

Minnesota

Medical School

University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ

Graduate School

Graduate School of Biomedical Sciences, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ

Residency

Internal Medicine, Clinical Investigator Program, Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN

Fellowship

Medical Oncology, Clinical Investigator Program, Mayo Graduate School of Medicine, Mayo Clinic, Rochester, MN

Certification

American Board of Internal Medicine

Academic Rank

Assistant Professor of Oncology

Interests

The role of the insulin-like growth factor (IGF) system in cancer cell growth and resistance to anti-cancer therapies (hormonal, chemotherapy, 'targeted', etc). The role of crosstalk between the IGF and HER/ErbB (e.g. EGFR, HER2/neu) families of receptors in anti-apoptotic signaling. Mechanism of resistance to IGF-1 receptor (IGF-1R) inhibitors. Clinical and translational studies of novel therapies for ovarian and breast cancers. Targeting minimal residual disease (MRD) in ovarian cancer.

Publications

See a listing of publications on PubMed, a service of the National Library of medicine.

Research

See a description of research activities.